Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility study of sorafenib in advanced hepatocellular carcinoma with HIV on HAART
2010-023602-12Phase 2Completed
- Sponsor
- Centro di Riferimento Oncologico di Aviano
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sorafenib in hepatocellular carcinoma (HCC) and human immunodeficiency virus infection (HIV), sponsored by Centro di Riferimento Oncologico di Aviano. Primary endpoint: Time to progression. Started Dec 2011; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-023602-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023602-12.